Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03935282 | Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors(AH-HA) | completed | N/A | 645 | Wake Forest University Health SciencesOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT01902680 | Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.(CURIEFOCALE) | completed | Phase 2 | 18 | Institut Claudius RegaudOTHER |
| 1 |
| Apr 14, 2026 |
| clinicaltrials |
| NCT01982786 | Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer | completed | N/A | 57 | Canadian Cancer Trials GroupNETWORK | 1 | Apr 13, 2026 | clinicaltrials |
| NCT02225704 | Radium-223 in Combination With Enzalutamide | completed | Phase 2 | 45 | Cancer Trials IrelandNETWORK | 1 | Apr 13, 2026 | clinicaltrials |
| NCT02772588 | AASUR in High Risk Prostate Cancer | completed | Phase 2 | 64 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT04081779 | Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study | completed | N/A | 261 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT04533958 | Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy(HypProMet) | completed | N/A | 53 | Saint-Gregoire Private Hospital CenterOTHER | 2 | Apr 6, 2026 | clinicaltrials |
| NCT04582656 | Efficacy Assessment of a Novel 3D Cartography-based Targeted Focal Microwave Therapy in Men With Localized Intermediate-risk Prostate Cancer(VIOLETTE) | completed | N/A | 76 | KoelisINDUSTRY | 2 | Apr 6, 2026 | clinicaltrials |
| NCT03660085 | Prostate Cancer - Patient Empowerment Program(PC-PEP) | completed | N/A | 140 | Nova Scotia Health AuthorityOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT07510685 | Closed-System Bladder Irrigation to Reduce Urinary Tract Infections After Endoscopic Urologic Surgery (IRIS Trial)(IRIS) | completed | N/A | 240 | University of PisaOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT02044354 | Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer(CABA-DOC) | completed | Phase 3 | 195 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT05553327 | Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy. | completed | N/A | 100 | Hospital Clinic of BarcelonaOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT03496805 | Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy | completed | Phase 2 | 106 | Wake Forest University Health SciencesOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT03674814 | Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer | completed | Phase 1 | 42 | University of ChicagoOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT05231915 | Prevalence of the c.853delT Mutation of the HOXB13 Gene in Prostate Cancer in Martinique(HOXB13_Mart) | completed | N/A | 465 | University Hospital Center of MartiniqueOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT04705038 | Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments | completed | N/A | 101 | University of ChicagoOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT06435546 | Adherence to Oral Therapies in Advanced Breast and Prostate Cancers(AdOTAC) | completed | N/A | 200 | Institut de Cancérologie de LorraineOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07074405 | Acceptability of Artificial Intelligence in the Diagnosis of Prostate Cancer(AccAI) | completed | N/A | 51 | Centre Hospitalier Universitaire de LiegeOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT06136598 | A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001) | completed | Phase 1 | 14 | Merck Sharp & Dohme LLCINDUSTRY | 1 | Mar 19, 2026 | clinicaltrials |
| NCT07477756 | A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients | completed | — | 1,247 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 19, 2026 | clinicaltrials |
| NCT07428642 | PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC. | completed | — | 168 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT01804712 | Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy | completed | Early Phase 1 | 8 | Christopher KaneOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT07464964 | Effects of Music Therapy on Anxiety and Distress Levels During Radionuclide Treatment in Prostate Cancer Patients(MUSIC-PRT) | completed | N/A | 60 | Dokuz Eylul UniversityOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT05012813 | Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer | completed | N/A | 28 | OHSU Knight Cancer InstituteOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT00160979 | Transrectal Tumour Oxygen - US Army | completed | Phase 2 | 186 | University Health Network, TorontoOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT00936390 | Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer | completed | Phase 3 | 1,538 | Radiation Therapy Oncology GroupNETWORK | 2 | Mar 6, 2026 | clinicaltrials |
| NCT01546987 | Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer | completed | Phase 3 | 239 | Radiation Therapy Oncology GroupNETWORK | 2 | Mar 6, 2026 | clinicaltrials |
| NCT01567800 | Prostate Hypoxia FAZA | completed | N/A | 18 | University Health Network, TorontoOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT05764005 | Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study | completed | N/A | 39 | University of Michigan Rogel Cancer CenterOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT06184867 | Choices About Genetic Testing And Learning Your Risk With Smart Technology(CATALYST) | completed | N/A | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT00063882 | Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 3 | 588 | Radiation Therapy Oncology GroupNETWORK | 2 | Mar 5, 2026 | clinicaltrials |
| NCT05008900 | Timing of Post-prostatectomy PSMA Imaging(TOPP) | completed | Phase 2 | 4 | University Health Network, TorontoOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT07448545 | Turkish Version of the UCLA Prostate Cancer Index | completed | — | 115 | Lokman Hekim UniversityOTHER_GOV | 1 | Mar 5, 2026 | clinicaltrials |
| NCT04288687 | A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects | completed | Phase 2 | 11 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT06472856 | Vasomotor Symptom Alleviation Through Acupuncture in Patients With Prostate Cancer(VASA Pro) | completed | N/A | 12 | University College CorkOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT07450157 | A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617 | completed | — | 6,448 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 4, 2026 | clinicaltrials |
| NCT01409200 | Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis | completed | Phase 2 | 73 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT04443062 | Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer(Bullseye) | completed | Phase 2 | 58 | Radboud University Medical CenterOTHER | 2 | Feb 27, 2026 | clinicaltrials |
| NCT06056791 | Study of INKmune in Patients With mCRPC (CaRe Prostate)(CaRe) | completed | Phase 1 / Phase 2 | 12 | Inmune Bio, Inc.INDUSTRY | 1 | Feb 27, 2026 | clinicaltrials |
| NCT03159676 | Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer | completed | — | 150 | Mayo ClinicOTHER | 1 | Feb 25, 2026 | clinicaltrials |
| NCT05968599 | A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer | completed | — | 2,731 | PfizerINDUSTRY | 1 | Feb 25, 2026 | clinicaltrials |
| NCT01314118 | IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen | completed | Phase 2 | 131 | Janssen Biotech, Inc.INDUSTRY | 1 | Feb 24, 2026 | clinicaltrials |
| NCT03568188 | Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate Cancer(FOCALE) | completed | Phase 2 | 174 | Hospices Civils de LyonOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT02899221 | Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation | completed | N/A | 3 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Feb 20, 2026 | clinicaltrials |
| NCT00809991 | Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate | completed | Phase 2 | 91 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT04048252 | Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy(PROSTED) | completed | — | 18 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT06235099 | Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer(Solar-Recur) | completed | Phase 3 | 235 | Curium US LLCINDUSTRY | 1 | Feb 18, 2026 | clinicaltrials |
| NCT07416812 | Targeted Prostate Cancer Screening in Men With BRCA1/2 Mutations(IMPACT) | completed | N/A | 25 | Institute of Oncology LjubljanaOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT07417475 | Robot-Assisted Radical Prostatectomy: the HOOD Technique Versus Standard Anterior Reconstruction | completed | N/A | 200 | Araz MusaevOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT02776436 | Reducing Dexamethasone Around Docetaxel Infusion(REDEX) | completed | Phase 1 | 46 | Leiden University Medical CenterOTHER | 1 | Feb 17, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Apr 15, 2026source: clinicaltrials